Recombinant Human KLK7 Protein，His

KLK7, or Kallikrein-related peptidase 7, is a member of the kallikrein family of serine proteases, which are known to play crucial roles in various physiological processes, including tissue remodeling, inflammation, and cancer progression. Research into KLK7 has gained momentum due to its association with several malignancies, particularly in breast and prostate cancers, where its overexpression has been linked to tumorigenesis and metastasis. The enzyme is believed to degrade extracellular matrix components and activate other proteases, contributing to the invasive characteristics of malignant cells. Additionally, KLK7 is implicated in skin physiology, influencing keratinocyte differentiation and wound healing. The study of KLK7, especially in the context of recombinant protein production, has the potential to uncover its functional mechanisms and therapeutic applications. By utilizing techniques in molecular biology, researchers aim to produce KLK7 in a recombinant form to facilitate detailed biochemical studies. Understanding the structure-function relationship of KLK7 could provide insights into its role in disease processes and may reveal novel targets for drug development, particularly in cancer therapeutics. Overall, KLK7 represents a significant biomarker and potential therapeutic target, and ongoing research continues to focus on elucidating its precise role in health and disease.